Abstract
We examined the effects of lifestyle and thoughts on cognitive function and change in cognitive function due to restrictions in daily life during the coronavirus disease 2019 (COVID-19) pandemic in community-dwelling older adults with mild cognitive decline. This was a retrospective case-control study. The participants were 88 older adults with mild cognitive decline who participated in a class designed to help prevent cognitive decline. The class was suspended from early-March to end of May 2020 to prevent the spread of COVID-19, and resumed in June 2020. We collected demographic and cognitive function test data (Touch Panel-type Dementia Assessment Scale [TDAS]) before and after class suspension and questionnaire data on their lifestyle and thoughts during the suspension. Change in TDAS scores from before and after the suspension was used to divide the participants into decline (2 or more points worsening) and non-decline (all other participants) groups, with 16 (18.2%) and 72 (81.8%) participants in each group, respectively. A logistic regression model showed that the odds ratio (OR) for cognitive decline was lower in participants whose responses were “engaged in hobbies” (OR = 0.07, p = 0.015), “worked on a worksheet about cognitive training provided by the town hall” (OR = 0.19, p = 0.026), and “had conversations over the phone” (OR = 0.28, p = 0.0495). There was a significant improvement in TDAS scores after class was resumed (p < 0.01). A proactive approach to intellectual activities and social ties may be important for the prevention of cognitive decline during periods of restrictions due to COVID-19. We found that cognitive function test scores before class suspension significantly improved after resuming classes. We speculate that continued participation in the class led to positive behavioral changes in daily life during periods of restriction due to COVID-19.
Competing Interest Statement
MK, SF, and KM have no conflicts of interest to declare. KU owns a patent on the Touch Panel-type Dementia Assessment Scale and receives royalties from Nihon Kohden Corporation (Tokyo, Japan).
Funding Statement
The authors received no specific funding for this work.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The ethics committee of Tottori University Faculty of Medicine (Yonago, Japan) approved the study (number: 20A076) and all procedures complied with the Declaration of Helsinki. The need for consent was waived by the ethics committee of Tottori University Faculty of Medicine because this was an observational study that used pre-collected information. The study was not considered neither invasive nor intervening, and an opt-out approach was employed. All information pertaining to the study was disclosed in advance on the homepage of the Tottori University website and the notice board of Houki town hall to ensure that participants were given the opportunity to decline participation.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The data sets used and/or analyzed during the current study are available from the corresponding author on request. However, access to the data sets will only be granted upon approval by all authors, the data provider (the Health measures section, Houki town), and the ethics committee.
